Maria Letizia Barreca

Title: Maria Letizia Barreca: Innovator in Neurodegenerative Disorder Treatments

Introduction

Maria Letizia Barreca is a prominent inventor based in Perugia, Italy. She has made significant contributions to the field of neurodegenerative disorders through her innovative research and inventions. Her work focuses on developing therapeutic agents that target protein aggregation, a key factor in many neurodegenerative diseases.

Latest Patents

Maria Letizia Barreca holds a patent for "Prion protein ligands as therapeutic agents for neurodegenerative disorders." This invention provides compositions and methods for treating neurodegenerative diseases, particularly those associated with protein aggregation. The invention is based on the discovery of binding regions on the surface of PrPc, known as PrPc Binding Domains (PBD). Specifically, she identified six different binding regions on PrPc, referred to as PBD-1 through PBD-6. These domains are defined by clusters of amino acids located in the globular domain of the protein, particularly in the C-terminal half of the protein, with one embodiment utilizing residues 127-226.

Career Highlights

Throughout her career, Maria Letizia Barreca has worked with esteemed institutions such as Boston University and Università di Perugia. Her research has significantly advanced the understanding of neurodegenerative disorders and has the potential to lead to new therapeutic approaches.

Collaborations

Maria has collaborated with notable colleagues, including Emiliano Biasini and David A. Harris. Their combined expertise has contributed to the success of her research and the development of her patented inventions.

Conclusion

Maria Letizia Barreca is a trailblazer in the field of neurodegenerative disorder treatments. Her innovative work and patented inventions hold promise for improving therapeutic options for patients suffering from these challenging conditions.